09.01.2015 Views

Understanding & Discussing Women's Sexual Functioning: How to ...

Understanding & Discussing Women's Sexual Functioning: How to ...

Understanding & Discussing Women's Sexual Functioning: How to ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Female/Male <strong>Sexual</strong> Arousal<br />

Disorder (302.72)<br />

A. Persistent or recurrent inability <strong>to</strong> attain,<br />

or <strong>to</strong> maintain until completion of the<br />

sexual activity, an adequate lubrication-<br />

swelling response of sexual excitement<br />

B. The disturbance causes marked distress or<br />

interpersonal difficulty<br />

C. The orgasmic dysfunction is not better accounted for<br />

by another Axis I disorder (except another <strong>Sexual</strong><br />

Dysfunction) and is not due exclusively <strong>to</strong> the direct<br />

physiological effects of a substance (e.g., a drug of<br />

abuse, a medication) or a general medical condition<br />

Vaginismus (306.51)<br />

A. Recurrent or persistent involuntary<br />

spasm of the musculature of the outer<br />

third of the vagina that interferes with<br />

sexual intercourse<br />

B. The disturbance causes marked distress or<br />

interpersonal difficulty<br />

C. The disturbance is not better accounted for by<br />

another Axis I disorder (e.g., Somatization Disorder) and<br />

is not due exclusively <strong>to</strong> the direct physiological effects<br />

of a general medical condition<br />

Female Orgasmic Disorder (302.73)<br />

A. Persistent or recurrent delay in, or absence of,<br />

orgasm following a normal sexual excitement phase.<br />

Women exhibit wide variability in the type or intensity<br />

of stimulation that triggers orgasm. The diagnosis of<br />

Female Orgasmic Disorder should be based on the<br />

clinician’s s judgment that the woman’s s orgasmic<br />

capacity is less than would be reasonable for her age,<br />

sexual experience, and the adequacy of sexual<br />

stimulation she receives.<br />

B. The disturbance causes marked distress or interpersonal<br />

difficulty<br />

C. The orgasmic dysfunction is not better accounted for by<br />

another Axis I disorder (except another <strong>Sexual</strong> Dysfunction) and<br />

is not due exclusively <strong>to</strong> the direct physiological effects of a<br />

substance (e.g., a drug of abuse, a medication) or a general<br />

medical condition<br />

Fac<strong>to</strong>rs affecting sexual functioning<br />

Medical Conditions<br />

– Geni<strong>to</strong>urinary<br />

– Vascular<br />

– Neurological<br />

– Endocrine<br />

Medications<br />

– Psychotropic (e.g. SSRIs)<br />

– OCPs<br />

Psychosocial fac<strong>to</strong>rs<br />

– <strong>Sexual</strong> his<strong>to</strong>ry (eg(<br />

trauma)<br />

– Messages about sexuality<br />

– Dyadic stress<br />

– Body Image<br />

– Mental Health (eg(<br />

depression, anxiety, “stress”)<br />

Dyspareunia (302.76)<br />

A. Recurrent or persistent genital pain<br />

associated with sexual intercourse<br />

B. The disturbance causes marked distress or<br />

interpersonal difficulty<br />

C. The orgasmic dysfunction is not caused exclusively<br />

by Vaginismus or lack of lubrication, is not better<br />

accounted for by another Axis I disorder (except another<br />

<strong>Sexual</strong> Dysfunction) and is not due exclusively <strong>to</strong> the<br />

direct physiological effects of a substance (e.g., a drug of<br />

abuse, a medication) or a general medical condition<br />

Prevalence of Female <strong>Sexual</strong><br />

Dysfunctions<br />

For women (as opposed <strong>to</strong> men) Hypoactive <strong>Sexual</strong> Desire Disorder<br />

(HSDD) decreases with age<br />

Vaginismus<br />

– 1% prevalence<br />

Dyspareunia –<br />

– 18-72% (US)<br />

– Likelihood may increase post-menopause<br />

Orgasmic disorder<br />

– Kinsey (1953) 10% lifetime prevalence anorgasmia<br />

– Laumann et al (1999) 24% 1-yr 1<br />

prevalence of problems<br />

– Depending on definition: 4-24% 4<br />

– Lower SES and less education related <strong>to</strong> lower likelihood <strong>to</strong> experience<br />

orgasm. (Laumann(<br />

et al, 1994)<br />

<strong>Sexual</strong> Arousal disorder<br />

– Problems with lubrication:14-43% 43% US, (1-yr prevalence); 6% Iceland<br />

(lifetime prevalence); 8% Sweden (1-yr prevalence)…..<br />

– Increases with age for both men and women<br />

2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!